Detection of an Abnormal Plasma Clot Structure by a Simple Rigidity Assay

Summary

We report here on a patient whose abnormal fibrin clot was detected via the measurement of clot rigidity with a simple buoyant inner cylinder elastometer. The patient’s clinical coagulation studies were all within normal limits except for prolonged thrombin and reptilase clotting times and a high level of fibrin split products. The measured rigidity of the patient’s clot was approximately ten times lower than that of a clot formed from normal pooled plasma. Light scattering studies indicated that this modified structure was not caused by a gross change in gel fiber morphology. Antithrombin activity was eliminated as a possible cause of the altered clot structure; this suggests the possibility of a modified fibrinogen. Abnormalities in the reptilase time and fibrinogen levels in two siblings support the hypothesis that the modification is an inherited defect. We suggest that the simple measurement of rigidity can be used routinely to detect abnormalities in plasma clot structure. The screening for such disorders should be of importance to clinician, patient, and biochemical researcher.

• References

• 1 Barrow E, Bullock W, Graham JB. 1960; A study of the carrier state for plasma thromboplastin component PTC Christmas factor deficiency, utilizing a new assay. Journal of Laboratory and Clinical Medicine 55: 936
• 2 Brecher G, Cronktte EP. 1950; Morphology and enumeration of blood platelets. Journal of Applied Physiology 3: 365
• 3 Carr ME, Hermans J. 1978; Size and density of fibrin fibers from turbidity. Macromolecules 11: 46
• 4 Carr ME, Shen LL, HERMANS J. 1976; A physical standard of fibrinogen: Measurement of the elastic modulus of dilute fibrin gels with a new elastometer. Analytical Biochemistry 72: 202
• 5 Carr ME, Shen LL, Hermans J. 1977; Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers 16: 1
• 6 Caspary EA, Kenwick RA. 1957; Some physiochemical properties of human fibrinogen. Biochemical Journal 67: 41
• 7 Felten A, Von. Duckert F, Frick P. 1965; Gerinnungsstorung ahne haemorrhagische diathese in Folge verziigerter aggregation der fibrinmolekule. Schweizerische Medizinische Wochenschrift 95: 1453
• 8 Hall CE, Slayter HS. 1959; The fibrinogen molecule: Its size, shape, and mode of polymerization. Journal of Biophysical Biochemical Cytology 5: 11
• 9 Imperato C, Dettori AG. 1958; Ipofibrinogenemia congenita con fibrinoastenia. Helvetica Paediatrica Acta 13: 380
• 10 Ivy AC, Shapiro PI, Melnick P. 1935; The bleeding tendency in jaundice. Surgery, Gynecology and Obstetrics 60: 781
• 11 Katz S, Gutfreund K, Shulman S, Ferry JD. 1952; The conversion of fibrinogen to fibrin. X. Light scattering studies of bovine fibrinogen. Journal of the American Chemical Society 74: 5706
• 12 Kazal LA, Amsel S, Miller OP, Tocantins LM. 1963; The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proceedings of the Society for Experimental Biology and Medicine 113: 989
• 13 Lorand L, Vrayama T, Dekiewiet JW C, Nossel HL. 1969; Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. Journal of Clinical Investigation 48: 1054
• 14 Quick AJ, Brown MS, Bancroft FW. 1935; A study of the coagulation defect in hemophilia and jaundice. American Journal of the Medical Sciences 190: 501
• 15 Rodman NF, Barrow EM, Graham JB. 1957; Stuart clotting defect. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called “stable factor” (SPCA, pro convertin, factor VII deficiency) Journal of Clinical Investigation 36: 485
• 16 Shen LL, McDonagh RP, Mcdonagh J, Hermans J. 1977; Early events in the plasmin digestion of fibrinogen and fibrin. Effects of plasmin and fibrin polymerization Journal of Biological Chemistry 252: 6184
• 17 Shulman S. 1953; The size and shape of bovine fibrinogen, studies of sedimental diffusion and viscosity. Journal of the American Chemical Society 75: 5846
• 18 Stryer L, Cohen C, Langridge R. 1963; Axial period of fibrinogen and fibrin. Nature 197: 793
• 19 Von Kaulla KN, Schultz RL. 1958; Methods for the evaluation of human fibrinolysis. American Journal of Clinical Pathology 29: 104
• 20 Williams J, Hermans J. 1978 Unpublished results.